AAPACN is dedicated to supporting post-acute care nurses provide quality care.

NIH COVID-19 Treatment Guidelines: Ritonavir-Boosted Nirmatrelvir (Paxlovid) Update

In May 2023, the Food and Drug Administration (FDA) approved the use of ritonavir-boosted nirmatrelvir (Paxlovid) for the treatment of certain adults with COVID-19. However, ritonavir-boosted nirmatrelvir was initially only available from Emergency Use Authorization...

Oops! This is member-only content.

Please login, sign up for a full membership, or sign up for a free 30-day trial membership to access this content.